Thermo Fisher Scientific Reports Strong Financial Results for Fourth Quarter and Full Year 2024WALTHAM, Mass. (January 30, 2025) – Thermo Fisher Scientific Inc. (NYSE: TMO) announced its financial results for the fourth quarter and full year ended De

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Thermo Fisher Scientific’s 8K filing here.

About Thermo Fisher Scientific

(Get Free Report)

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Featured Stories